New antibody shows promise in reducing tau proteins associated with Alzheimer's disease

A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alzheimer's disease.

Related Keywords

Massachusetts ,United States ,Colombia ,Claudia Marino ,Josephf Arboleda Velasquez ,Danielle Ellis ,Journal Of The Alzheimer Association ,Department Of Ophthalmology At Mass Eye ,Mass General Brigham ,Mass Eye ,Massachusetts General Hospital ,Antibody ,Reclinical ,Lzheimer 39s Disease ,Antibodies ,Biogen ,Dementia ,Ear ,Eye ,Gene ,Enetic ,Hospital ,Monoclonal Antibody ,Research ,Herapeutics ,